Peptide Modification Diminishes HLA Class II-restricted CD4<sup>+</sup> T Cell Recognition of Prostate Cancer Cells

Peptide Modification Diminishes HLA Class II-restricted CD4<sup>+</sup> T Cell Recognition of Prostate Cancer Cells

Prostate cancer poses an ongoing problem in the western world accounting for significant morbidity and mortality in the male population. Current therapy options are effective in treating most prostate cancer patients, but a significant number of patients progress beyond a manageable disease. For the...

Full description

Bibliographic Details
Main Authors: Bently P. Doonan, Shereen Amria, Jennifer R. Bethard, Narendra L. Banik, Jessica D. Hathaway-Schrader, Azizul Haque
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
prostate cancer
prostate-specific membrane protein
HLA class II
cysteinylation
GILT
antigen presentation
Online Access:https://www.mdpi.com/1422-0067/23/23/15234

Similar Items

Similar Items